Targeting the insulin-like growth factor receptor.
Yee
Douglas
D
Division of Hematology, Oncology, and Transplantation, Women's Cancer Program, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
D000970:Antineoplastic Agents; D017321:Clinical Trials, Phase I as Topic; D015195:Drug Design; D006801:Humans; D017451:Receptors, Somatomedin / Q000037:antagonists & inhibitors* / Q000187:drug effects* / Q000502:physiology
D000970:Antineoplastic Agents; D017451:Receptors, Somatomedin